Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 May;64(5):1365-70.
doi: 10.1086/302372.

The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements

Affiliations

The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements

A Echaniz-Laguna et al. Am J Hum Genet. 1999 May.

Abstract

Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disorder characterized by degeneration of motor neurons of the spinal cord. The survival motor neuron gene (SMN) has been recognized as the disease-causing gene. SMN is duplicated, and the almost identical copy gene (SMNc) remains functional in patients with SMA. The expression level of SMNc is tightly correlated with the clinical severity of the disease. Here, we define the transcription initiation site, delineate the region containing promoter activity, and analyze the sequence of the promoter region of both SMN and SMNc. We show that the promoter sequence and activity of the two genes are quasi identical, providing strong evidence for similar transcription regulation of the two genes. Therefore, the difference in the level of protein encoded by SMN and SMNc is the result of either different regulatory region(s) further apart or different posttranscriptional regulation. Interestingly, sequence analysis of the promoter region revealed several consensus binding sites for transcription factors. Therefore, the identification of transcription factors involved in the regulation of SMNc gene expression may lead to attractive strategies for therapy in SMA.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cell. 1985 Jun;41(2):509-20 - PubMed
    1. Nat Genet. 1997 Jul;16(3):265-9 - PubMed
    1. Cell. 1991 Feb 22;64(4):739-49 - PubMed
    1. J Biomol Struct Dyn. 1991 Oct;9(2):387-97 - PubMed
    1. Gene. 1992 Jan 2;110(1):129-30 - PubMed

Publication types

Substances

Associated data

LinkOut - more resources